Sign In
Buy TERN
Terns Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -68.15. In total, the insiders bought 1.44M and sold 6.05M TERN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-68.15 |
| ● Buy | 1.44M shares |
| ● Sell | 6.05M shares |
|
31% Buy Activity
Moderate Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jan 15, 2026 Buy |
Burroughs Amy L. Chief Executive Officer |
14 583 Value: $67.7K |
||
|
Jan 15, 2026 Buy |
Burroughs Amy L. Chief Executive Officer |
27 083 Value: $125.7K |
||
|
Jan 14, 2026 Buy |
Burroughs Amy L. Chief Executive Officer |
150 000 Value: $5.58M |
||
|
Jan 14, 2026 Buy |
Gengos Andrew Chief Financial Officer |
68 750 Value: $2.56M |
||
|
Jan 14, 2026 Buy |
Kuriakose Emil Chief Medical Officer |
112 500 Value: $4.18M |
||
|
Jan 14, 2026 Buy |
Kuriakose Emil Chief Medical Officer |
56 250 Value: $2.09M |
||
|
Jan 14, 2026 Buy |
Gengos Andrew Chief Financial Officer |
137 500 Value: $5.11M |
||
|
Jan 14, 2026 Buy |
Burroughs Amy L. Chief Executive Officer |
300 000 Value: $11.2M |
||
|
Jan 05, 2026 Sell |
Burroughs Amy L. Chief Executive Officer |
71 339 Value: $2.72M |
||
|
Jan 05, 2026 Buy |
Burroughs Amy L. Chief Executive Officer |
150 000 Value: $5.88M |
||
|
Jan 05, 2026 Buy |
Burroughs Amy L. Chief Executive Officer |
150 000 Value: $5.88M |
||
|
Jan 02, 2026 Sell |
Kuriakose Emil Chief Medical Officer |
955 Value: $36.6K |
||
|
Jan 02, 2026 Buy |
Burroughs Amy L. Chief Executive Officer |
21 551 Value: $100.0K |
||
|
Jan 02, 2026 Buy |
Burroughs Amy L. Chief Executive Officer |
21 551 Value: $100.0K |
||
|
Jan 02, 2026 Sell |
Kuriakose Emil Chief Medical Officer |
200 Value: $8K |
||
|
Nov 04, 2025 Buy |
Quigley Jill M. Director |
24 520 Value: $226.6K |
||
|
Nov 04, 2025 Buy |
Quigley Jill M. Director |
24 520 Value: $226.6K |
||
|
Nov 04, 2025 Sell |
Quigley Jill M. Director |
24 520 Value: $441.4K |
||
|
Oct 01, 2025 Sell |
Kuriakose Emil Chief Medical Officer |
944 Value: $7K |
||
|
Oct 01, 2025 Sell |
Kuriakose Emil Chief Medical Officer |
944 Value: $7K |
||
|
Jul 01, 2025 Sell |
Kuriakose Emil Chief Medical Officer |
853 Value: $4K |
||
|
Jul 01, 2025 Sell |
Kuriakose Emil Chief Medical Officer |
853 Value: $4K |
||
|
Jun 27, 2025 Buy |
Gengos Andrew Chief Financial Officer |
5 000 Value: $19.6K |
||
|
Jun 27, 2025 Buy |
Gengos Andrew Chief Financial Officer |
5 000 Value: $19.6K |
||
|
Jun 27, 2025 Buy |
Gengos Andrew Chief Financial Officer |
5 000 Value: $19.6K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
